The Rationale and Design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) Trial
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 22 (2), 176-190
- https://doi.org/10.1016/s0197-2456(01)00111-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- British HIV Association guidelinesThe Lancet, 1998
- British HIV Association guidelinesThe Lancet, 1998
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Sample size determination in clinical trials with time-dependent rates of losses and noncomplianceControlled Clinical Trials, 1986
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983